Ann: Investor Presentation & Webcast Link, page-63

First 63 Last

Share
Profile

Follow
BPAA

4,736 Posts.

873

16/05/25

12:18

Post #: 79071436
Share

Originally posted by Sojourner: ↑

What were you expecting? All market sensitive announcements are issued when necessary as per ASX rules.

We got a few more insights into some aspects of the business which is what was expected, plus confirmation again, the company is doing fine with capital and will probably end the half with more money than it started with.

India is doing better than I thought it was. They’re reaching a lot of hospitals and the sales price they have been achieving is at above the top end of what I thought they’d been able to achieve.

Great news on recruitment in the U.S now that PNV is no longer seen as a risky unknown player but a well established and growing business.

More insight was given into the work with Beta Cell and how this could be a company maker in its own right. It’s still early days, but given BTM already has approval and any drug it is used for drug delivery will also be approved - it is possible that entry into this market could happen sooner than what the market thinks. This is potentially a massive market.

A great insight was that the procedure for this could be done under local anaesthetic with the patient fully awake, and they go home the same day! This is going to be a huge quality of life improvement for those that can access it. I’m quietly excited about the progress in this area.

Expand

He isn't a long term holder, 1st post 12 months ago

Just another ignorant poster who can't decipher information, so assumes there was nothing in it

PNV Price at posting: $1.50 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

RCE

Recce locks in $30M to boost commercialisation across ASEAN region

First 63 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.22		Change 0.000(0.00%)		Mkt cap ! $839.3M

Open	High	Low	Value	Volume
$1.22	$1.25	$1.21	$1.808M	1.476M

Buyers (Bids)

No.	Vol.	Price($)
4	14866	$1.21

Sellers (Offers)

Price($)	Vol.	No.
$1.22	12554	1

View Market Depth

No.	Vol.	Price($)
4	14866	1.210
3	25149	1.205
3	39404	1.200
3	22537	1.195
1	9366	1.190

Price($)	Vol.	No.
1.220	12554	1
1.225	6871	2
1.240	27133	4
1.245	17805	2
1.250	31553	6

Last trade - 16.10pm 17/06/2025 (20 minute delay)

PNV (ASX) Chart

Ann: Investor Presentation & Webcast Link, page-63

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

Many are concerned about global falling birthrates. This diverse stock has solutions

Recce locks in $30M to boost commercialisation across ASEAN region

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Investor Presentation & Webcast Link, page-63

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

Many are concerned about global falling birthrates. This diverse stock has solutions

Recce locks in $30M to boost commercialisation across ASEAN region

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News